Trial Information
Inclusion Criteria:
- pathologic proven colon cancer
Exclusion Criteria:
- Tumor located in distal transverse colon, splenic flexure, and descending colon
- distant metastasis
- acute obstruction and/or perforation
- associated with FAP or HNPCC
- synchronous malignancy
- ASA score 3 or 4
- pregnancy
- no consent
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
rate of intraoperative complication
Outcome Time Frame:
1 day
Safety Issue:
Yes
Principal Investigator
Suk Hwan Lee, MD. PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Kyung Hee University School of Medicine
Authority:
South Korea: Korea Food and Drug Administration (KFDA)
Study ID:
KHNMC IRB 2010-007
NCT ID:
NCT01203969
Start Date:
June 2010
Completion Date:
March 2011
Related Keywords:
- Colon Cancer
- Colonic Neoplasms